Press Releases

Kite Pharma to Host Second Quarter 2015 Financial Results Conference Call and Webcast

SANTA MONICA, Calif.Aug. 6, 2015Kite Pharma, Inc.4:30 p.m. Eastern Time on MondayAugust 10, 2015June 30, 2015

To access the live conference call via phone, please dial (844) 856-8656. International callers may access the live call by dialing (443) 877-4062. The conference ID number for the live call is 98583072.

The live and archived webcast can be accessed through the Calendar of Events section of the Company's website at Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. A replay of the webcast will be available on the Company's website for two weeks following the event.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit

CONTACT: Kite PharmaCynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer


         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol WertherBurns McClellan


Kite Pharma, Inc.

News Provided by Acquire Media